Panagora Asset Management Inc Checkpoint Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.5 - $3.53 $13,272 - $18,740	-5,309 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$2.19 - $2.96 $6,758 - $9,134	-3,086 Reduced 36.76%	5,309 $14,000
Q1 2020 May 14, 2020	BUY	$1.11 - $2.43 $9,318 - $20,399	8,395 New	8,395 $13,000
Q1 2019 May 15, 2019	SELL	$2.01 - $4.01 $18,146 - $36,202	-9,028 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.54 - $3.35 $17,241 - $37,506	-11,196 Reduced 55.36%	9,028 $16,000
Q3 2018 Nov 13, 2018	SELL	$2.46 - $4.72 $2,376 - $4,559	-966 Reduced 4.56%	20,224 $72,000
Q2 2018 Aug 14, 2018	BUY	$2.45 - $4.39 $22,076 - $39,558	9,011 Added 73.99%	21,190 $63,000
Q1 2018 May 15, 2018	BUY	$3.24 - $5.6 $39,459 - $68,202	12,179 New	12,179 $53,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $245M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.